A detailed history of Telligent Fund, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Telligent Fund, LP holds 11,000 shares of LLY stock, worth $8.84 Million. This represents 8.08% of its overall portfolio holdings.

Number of Shares
11,000
Holding current value
$8.84 Million
% of portfolio
8.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

BUY
$727.2 - $932.06 $8 Million - $10.3 Million
11,000 New
11,000 $8.49 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $764B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Telligent Fund, LP Portfolio

Follow Telligent Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telligent Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Telligent Fund, LP with notifications on news.